A TCR-switchable cell death pathway in T-ALL

Oncoscience. 2017 Mar 31;4(3-4):17-18. doi: 10.18632/oncoscience.342. eCollection 2017 Mar.

Authors

Christine Tran Quang¹, Benedetta Zaniboni¹, Jacques Ghysdael¹

Affiliation

¹ Institut Curie, PSL Research University, CNRS UMR 3348, F-91405, Orsay, France; Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, F-91405 Orsay, France.

No abstract available

Keywords: T-ALL; TCR signaling; cell death; negative selection; targeted therapy.

Publication types

Editorial